<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>10220752</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Romagosa, V</dc:author>
<dc:author>Fernández de Sevilla, A</dc:author>
<dc:author>Domingo-Claros, A</dc:author>
<dc:author>Salar, A</dc:author>
<dc:author>Grañena, A</dc:author>
<dc:author>González-Barca, E</dc:author>
<dc:description xml:lang="en">BACKGROUND To analyze peripheral non-cutaneous T-cell lymphomas (NC-TCL) and to test the significance of the IPI. PATIENTS AND METHODS Twenty-nine consecutive patients diagnosed with NC-TCL according to the REAL classification. RESULTS At diagnosis were common: B symptoms (21%), stage III/IV (55%), high LDH level (55%) and extranodal involvement (79%). Twelve (48%) patients achieved complete remission. The IPI identified groups of patients with different response to therapy and survival. CONCLUSIONS NC-TCL with high or high-intermediate IPI had a short survival if treated with CHOP.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1999 Feb 27 </dc:date>
<dc:title xml:lang="es">Linfomas T periféricos sin afectación cutánea primaria. Estudio anatomoclínico de 29 casos consecutivos.</dc:title>
<dc:title xml:lang="en">[Peripheral T-cell lymphomas without primary skin involvement. An anatomicoclinical study of 29 consecutive cases].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
